HJB - Your Trusted Biologics CDMO Partner
HJB, CDMO, biologics, HJB Bio, hjbbio, China CDMO, 杭州奕安济世, Just Bio, Just biotherapeutics, HJB bio, HJB China, Hangzhou HJB
Antibody drug conjugates (ADCs) represent a complex, yet promising class of therapeutics designed to address unmet medical needs. Leveraging our deep expertise in conjugation principles and extensive experience in Designing of Experiments (DOE), we are committed to providing world-class ADC CDMO services. Our approach emphasizes collaboration, growth, and flexibility tailored to our partners’ unique requirements.
We are particularly strong in early-stage development, offering a ready inventory of model antibodies to facilitate linker and payload selection, accelerating your development timeline. Our platform expertise and high-throughput screening capabilities are designed to optimize conjugation processes, lyophilization, and analytical method development to meet your specific needs.
Furthermore, we excel in seamless technology transfer to third-party manufacturers and can coordinate all CMC activities, ensuring a smooth transition from development to clinical trials or commercial readiness.
CDMO@hjbbio.com
